Scientific Team

Received numerous awards

2017

Named one of the top 10 inventors of the Institut Pasteur by the National Academy of Inventors NAI (USA)

TheraVectys benefits from the experience of greatest specialist in Lentiviral vectors
which peer-reviewed papers have paved the way to gene therapy.

Laleh Majlessi, PhD in cellular immunology, is Director of Research at Institut Pasteur, Paris. At the Pasteur-TheraVectys Joint Laboratory, she leads research and development on the pioneering use of lentiviral vectors in vaccination against infectious diseases and in immunotherapy of cancers. Author of numerous publications and holder of numerous application patents, Laleh Majlessi also works to translate preclinical results and proofs of concept into clinical applications. She was awarded the Jean-Marie Dubert Prize for her Ph.D thesis in cellular immunology and the Georges, Jacques and Elias Canetti Prize for her research on anti-mycobacterial immunity.

After working as a researcher in the field of vaccines and immunotherapy, Christian Bréchot was president and general manager of the largest scientific institutions in the field of health in France.
Dr. Brechot is currently the Senior Associate Dean for Research in Global Affairs and the Associate Vice-President for International Partnerships and Innovation at the University of South Florida, Tampa, USA.
Additionally, he is currently the President of the Global Virus Network, Baltimore, USA and was the former President of the Institut Pasteur, Paris, France.